MedTrace Logo

E-cigarettes, Nicotine Inhaler, and Blood Vessel Function

NCT03072628 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2023-10-04

No results posted yet for this study

Summary

Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, nicotine inhaler, and sham-control on endothelial function, oxidative stress and sympathetic nerve activity

Conditions

  • Nicotine Dependence

Interventions

OTHER

e-cig with nicotine

use an e-cig with nicotine for 30 minutes

OTHER

e-cig without nicotine

use an e-cig without nicotine for 30 minutes

OTHER

nicotine inhaler

use a nicotine inhaler for 30 minutes

OTHER

sham control

use an empty e-cigarette for 30 minutes

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-11
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03072628 on ClinicalTrials.gov